Clinical significance of circulating-tumour DNA analysis by metastatic sites in pancreatic cancer

被引：0
|
作者：
Kumiko Umemoto
Yu Sunakawa
Makoto Ueno
Masayuki Furukawa
Nobumasa Mizuno
Kentaro Sudo
Yasuyuki Kawamoto
Takeshi Kajiwara
Koushiro Ohtsubo
Naohiro Okano
Nobuhisa Matsuhashi
Shinji Itoh
Toshihiko Matsumoto
Satoshi Shimizu
Toru Otsuru
Hiroko Hasegawa
Hiroyuki Okuyama
Hideko Ohama
Toshikazu Moriwaki
Takashi Ohta
Justin I. Odegaard
Yoshiaki Nakamura
Hideaki Bando
Takayuki Yoshino
Masafumi Ikeda
Chigusa Morizane
机构：
[1] St. Marianna University School of Medicine,Department of Clinical Oncology
[2] Kanagawa Cancer Center,Department of Gastroenterology
[3] National Hospital Organization Kyushu Cancer Center,Department of Hepato
[4] Aichi Cancer Center Hospital,Biliary
[5] Chiba Cancer Center,Pancreatology
[6] Hokkaido University Hospital,Department of Gastroenterology
[7] National Hospital Organization Shikoku Cancer Center,Department of Gastroenterology
[8] Cancer Research Institute,Division of Cancer Center
[9] Kanazawa University,Department of Gastrointestinal Medical Oncology
[10] Kyorin University Faculty of Medicine,Division of Medical Oncology
[11] Gifu University,Department of Medical Oncology
[12] Kyushu University,Department of Gastroenterological Surgery
[13] Kobe City Medical Center General Hospital,Department of Surgery and Science, Graduate School of Medical Sciences
[14] Saitama Cancer Center,Department of Medical Oncology
[15] Osaka University Graduate School of Medicine,Department of Gastroenterology
[16] Osaka National Hospital,Department of Gastroenterological Surgery
[17] Kagawa University,Department of Gastroenterology and Hepatology, National Hospital Organization
[18] Osaka Medical College,Department of Clinical Oncology
[19] University of Tsukuba Hospital,Department of Gastroenterology
[20] Kansai Rosai Hospital,Department of Gastroenterology
[21] Guardant Health,Department of Clinical Oncology
[22] National Cancer Center Hospital East,Department of Gastroenterology and Gastrointestinal Oncology
[23] National Cancer Center Hospital East,Translational Research Support Section
[24] National Cancer Center Hospital East,Department of Hepatobiliary and Pancreatic Oncology
[25] National Cancer Center Hospital,Department of Hepatobiliary and Pancreatic Oncology
来源：
British Journal of Cancer | 2023年 / 128卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1603 / 1608
页数：5
相关论文
共 50 条
  • [41] Circulating tumour DNA as a cancer biomarker
    Duffy, Michael J.
    ANNALS OF CLINICAL BIOCHEMISTRY, 2019, 56 (01) : 42 - 48
  • [42] ANALYSIS OF THE PROGNOSTIC SIGNIFICANCE OF CIRCULATING TUMOR DNA (CTDNA) IN METASTATIC CASTRATE RESISTANT PROSTATE CANCER (MCRPC)
    Shaya, Justin
    Randall, J. Michael
    Millard, Frederick
    Kurzrock, Razelle
    Parsons, J. Kellogg
    Tamayo, Pablo
    McKay, Rana
    JOURNAL OF UROLOGY, 2020, 203 : E1094 - E1095
  • [43] Significant impact of circulating tumour DNA mutations on survival in metastatic breast cancer patients
    Muendlein, Axel
    Geiger, Kathrin
    Gaenger, Stella
    Dechow, Tobias
    Nonnenbroich, Christoph
    Leiherer, Andreas
    Drexel, Heinz
    Gaumann, Andreas
    Jagla, Wolfgang
    Winder, Thomas
    Mayer, Frank
    Decker, Thomas
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [44] Circulating tumour DNA characterisation of invasive lobular carcinoma in patients with metastatic breast cancer
    Davis, Andrew A.
    Gerratana, Lorenzo
    Clifton, Katherine
    Medford, Arielle J.
    Velimirovic, Marko
    Hensing, Whitney L.
    Bucheit, Leslie
    Shah, Ami N.
    D'Amico, Paolo
    Reduzzi, Carolina
    Zhang, Qiang
    Dai, Charles S.
    Denault, Elyssa N.
    Bagegni, Nusayba A.
    Opyrchal, Mateusz
    Ademuyiwa, Foluso O.
    Bose, Ron
    Gradishar, William J.
    Behdad, Amir
    Ma, Cynthia X.
    Bardia, Aditya
    Cristofanilli, Massimo
    EBIOMEDICINE, 2022, 86
  • [45] Significant impact of circulating tumour DNA mutations on survival in metastatic breast cancer patients
    Axel Muendlein
    Kathrin Geiger
    Stella Gaenger
    Tobias Dechow
    Christoph Nonnenbroich
    Andreas Leiherer
    Heinz Drexel
    Andreas Gaumann
    Wolfgang Jagla
    Thomas Winder
    Frank Mayer
    Thomas Decker
    Scientific Reports, 11
  • [46] Profiling circulating tumour cells and cell free DNA together in metastatic colon cancer
    Friend, Thomas
    Stebbing, Justin
    BRITISH JOURNAL OF CANCER, 2021, 125 (07) : 907 - 908
  • [47] Profiling circulating tumour cells and cell free DNA together in metastatic colon cancer
    Thomas Friend
    Justin Stebbing
    British Journal of Cancer, 2021, 125 : 907 - 908
  • [48] Clinical potential of circulating free DNA and circulating tumour cells in patients with metastatic non-small-cell lung cancer treated with pembrolizumab
    Mondelo-Macia, Patricia
    Garcia-Gonzalez, Jorge
    Leon-Mateos, Luis
    Anido, Urbano
    Aguin, Santiago
    Abdulkader, Ihab
    Sanchez-Ares, Maria
    Abalo, Alicia
    Rodriguez-Casanova, Aitor
    Diaz-Lagares, Angel
    Lago-Leston, Ramon Manuel
    Muinelo-Romay, Laura
    Lopez-Lopez, Rafael
    Diaz-Pena, Roberto
    MOLECULAR ONCOLOGY, 2021, 15 (11) : 2923 - 2940
  • [49] Early identification of treatment effect by methylated circulating tumour DNA in metastatic colorectal cancer
    Thomsen, C. B.
    Hansen, T. F.
    Andersen, R. F.
    Jensen, L. H.
    Jakobsen, A.
    ANNALS OF ONCOLOGY, 2019, 30
  • [50] Clinical significance of circulating tumour cells and tumour marker detection in the chemotherapeutic evaluation of advanced colorectal cancer
    Shen, Feifei
    Zhu, Yiwen
    Wang, Fan
    Cai, Xun
    Ding, Honghua
    Zhou, Fei
    Wang, Jingjue
    Gu, Hongli
    Liu, Chuan
    Li, Qi
    COLORECTAL DISEASE, 2022, 24 (01) : 68 - 76
12345